2022
DOI: 10.1212/wnl.0000000000200937
|View full text |Cite
|
Sign up to set email alerts
|

Pilot Randomized Clinical Trial of a Goals-of-Care Decision Aid for Surrogates of Patients With Severe Acute Brain Injury

Abstract: Background and Objectives:Breakdowns in clinician-family communication in neurologic intensive care units (neuroICUs) are common, particularly for goals-of-care decisions to continue or withdraw life-sustaining treatments while considering long-term prognoses. Shared decision-making interventions (decision aids [DAs]) may prevent this problem and increase patient-centered care, yet none are currently available. We assessed the feasibility, acceptability, and perceived usefulness of a DA for goals-of-care commu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
34
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(34 citation statements)
references
References 39 publications
0
34
0
Order By: Relevance
“…Our findings suggest that these approaches need to account not only for surrogates’ “preferred degree of control” over decision-making but also whether surrogates even perceive there being a decision to make. Those surrogates who, for varied reasons, do not perceive themselves as making decisions may not benefit in the same way from strategies like time-limited trials (16), decision-aids (22, 23), or from repeated discussions of prognosis and treatment options, at least during the acute phase of care in the ICU. Instead, our data suggests that “no choice” surrogates might need prognostic communication to focus less on decision-making and more on the acknowledgement of uncertainty and its contribution to the surrogate’s coping, as well as on assurance of a longitudinal relationship.…”
Section: Discussionmentioning
confidence: 99%
“…Our findings suggest that these approaches need to account not only for surrogates’ “preferred degree of control” over decision-making but also whether surrogates even perceive there being a decision to make. Those surrogates who, for varied reasons, do not perceive themselves as making decisions may not benefit in the same way from strategies like time-limited trials (16), decision-aids (22, 23), or from repeated discussions of prognosis and treatment options, at least during the acute phase of care in the ICU. Instead, our data suggests that “no choice” surrogates might need prognostic communication to focus less on decision-making and more on the acknowledgement of uncertainty and its contribution to the surrogate’s coping, as well as on assurance of a longitudinal relationship.…”
Section: Discussionmentioning
confidence: 99%
“…A recent pilot study had promising results for a decision aid created specifically for patients with SABI. 106 Two strategies that have been found to improve SABI outcomes are transferring patients to specialty centers and using dedicated neurointensive care units. [110][111][112][113] One reason for these improved outcomes may be that decision making improves with such specialization, including greater prognostic accuracy and fewer opportunities for cognitive bias.…”
Section: Proposed Interventionsmentioning
confidence: 99%
“…The many attempts to improve communication between clinicians and surrogates have had mixed results. [104][105][106] Effective communication may require not just better listening skills, but also guidance in how to convey the uncertain realities, unfamiliar outcomes, and unusual roles inherent to SDM in SABI. Decision science has a long history of communicating technical information to lay decision makers.…”
Section: Proposed Interventionsmentioning
confidence: 99%
“…In this issue of Neurology ® , Muehlschlegel et al 5 reported an unblinded, randomized pilot trial conducted at 2 tertiary-level Neuro-ICUs to test the feasibility and utility of this DA to promote education, communication, and preparation for goals of care discussions for surrogates of patients admitted after ischemic stroke, intracerebral hemorrhage, or traumatic brain injury. The authors found that most surrogates randomized to the intervention found it to be "good" or "excellent" (82%) and useful (92%).…”
Section: Study Fundingmentioning
confidence: 99%